Kashiv Pharma Swallows Up Adello Biologics, Becoming Kashiv BioSciences

 
• By Dean Rudge

New Jersey-based Kashiv adds biosimilar assets to its repertoire by acquiring Adello Biologics, becoming, in its own words, a “fully-integrated biosciences company with an expanded and dynamic platform for growth.” Adello’s CEO, Chintu Patel, will lead the combination.

Meeting
Kashiv has shaken hands on a deal for Adello • Source: Shutterstock

More from Deals

More from Business